Global Fabry Disease Therapeutic Market Insights, Forecast to 2025

Table of Contents

1 Study Coverage

• 1.1 Fabry Disease Therapeutic Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Fabry Disease Therapeutic Market Size Growth Rate by Product
  • 1.4.2 Enzyme Replacement Therapy
  • 1.4.3 Alternative therapies
• 1.5 Market by End User
  • 1.5.1 Global Fabry Disease Therapeutic Market Size Growth Rate by End User
  • 1.5.2 Hospitals
  • 1.5.3 Clinics
  • 1.5.4 Other
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Fabry Disease Therapeutic Market Size
  • 2.1.1 Global Fabry Disease Therapeutic Revenue 2014-2025
  • 2.1.2 Global Fabry Disease Therapeutic Sales 2014-2025
• 2.2 Fabry Disease Therapeutic Growth Rate by Regions
  • 2.2.1 Global Fabry Disease Therapeutic Sales by Regions
  • 2.2.2 Global Fabry Disease Therapeutic Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Fabry Disease Therapeutic Sales by Manufacturers
  • 3.1.1 Fabry Disease Therapeutic Sales by Manufacturers
  • 3.1.2 Fabry Disease Therapeutic Sales Market Share by Manufacturers
  • 3.1.3 Global Fabry Disease Therapeutic Market Concentration Ratio (CR5 and HHI)
• 3.2 Fabry Disease Therapeutic Revenue by Manufacturers
  • 3.2.1 Fabry Disease Therapeutic Revenue by Manufacturers (2014-2019)
  • 3.2.2 Fabry Disease Therapeutic Revenue Share by Manufacturers (2014-2019)
• 3.3 Fabry Disease Therapeutic Price by Manufacturers
• 3.4 Fabry Disease Therapeutic Manufacturing Base Distribution, Product Types
  • 3.4.1 Fabry Disease Therapeutic Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Fabry Disease Therapeutic Product Type
  • 3.4.3 Date of International Manufacturers Enter into Fabry Disease Therapeutic Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global Fabry Disease Therapeutic Sales by Product
• 4.2 Global Fabry Disease Therapeutic Revenue by Product
• 4.3 Fabry Disease Therapeutic Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global Fabry Disease Therapeutic Breakdown Data by End User

6 North America

• 6.1 North America Fabry Disease Therapeutic by Countries
  • 6.1.1 North America Fabry Disease Therapeutic Sales by Countries
  • 6.1.2 North America Fabry Disease Therapeutic Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Fabry Disease Therapeutic by Product
• 6.3 North America Fabry Disease Therapeutic by End User

7 Europe

• 7.1 Europe Fabry Disease Therapeutic by Countries
  • 7.1.1 Europe Fabry Disease Therapeutic Sales by Countries
  • 7.1.2 Europe Fabry Disease Therapeutic Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Fabry Disease Therapeutic by Product
• 7.3 Europe Fabry Disease Therapeutic by End User

8 Asia Pacific

• 8.1 Asia Pacific Fabry Disease Therapeutic by Countries
  • 8.1.1 Asia Pacific Fabry Disease Therapeutic Sales by Countries
  • 8.1.2 Asia Pacific Fabry Disease Therapeutic Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Fabry Disease Therapeutic by Product
• 8.3 Asia Pacific Fabry Disease Therapeutic by End User

9 Central & South America

• 9.1 Central & South America Fabry Disease Therapeutic by Countries
  • 9.1.1 Central & South America Fabry Disease Therapeutic Sales by Countries
  • 9.1.2 Central & South America Fabry Disease Therapeutic Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America Fabry Disease Therapeutic by Product
• 9.3 Central & South America Fabry Disease Therapeutic by End User

10 Middle East and Africa

• 10.1 Middle East and Africa Fabry Disease Therapeutic by Countries
  • 10.1.1 Middle East and Africa Fabry Disease Therapeutic Sales by Countries
  • 10.1.2 Middle East and Africa Fabry Disease Therapeutic Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Fabry Disease Therapeutic by Product
• 10.3 Middle East and Africa Fabry Disease Therapeutic by End User

11 Company Profiles

• 11.1 Amicus therapeutics
  • 11.1.1 Amicus therapeutics Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 Amicus therapeutics Fabry Disease Therapeutic Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 Amicus therapeutics Fabry Disease Therapeutic Products Offered
  • 11.1.5 Amicus therapeutics Recent Development
• 11.2 Shire
  • 11.2.1 Shire Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 Shire Fabry Disease Therapeutic Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 Shire Fabry Disease Therapeutic Products Offered
  • 11.2.5 Shire Recent Development
• 11.3 Genzyme-Sanofi
  • 11.3.1 Genzyme-Sanofi Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 Genzyme-Sanofi Fabry Disease Therapeutic Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 Genzyme-Sanofi Fabry Disease Therapeutic Products Offered
  • 11.3.5 Genzyme-Sanofi Recent Development
• 11.4 Protalix
  • 11.4.1 Protalix Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 Protalix Fabry Disease Therapeutic Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 Protalix Fabry Disease Therapeutic Products Offered
  • 11.4.5 Protalix Recent Development
• 11.5 Sanofi-Aventis LLC
  • 11.5.1 Sanofi-Aventis LLC Company Details
  • 11.5.2 Company Business Overview
  • 11.5.3 Sanofi-Aventis LLC Fabry Disease Therapeutic Sales, Revenue and Gross Margin (2014-2019)
  • 11.5.4 Sanofi-Aventis LLC Fabry Disease Therapeutic Products Offered
  • 11.5.5 Sanofi-Aventis LLC Recent Development
• 11.6 Novartis Pharmaceuticals
  • 11.6.1 Novartis Pharmaceuticals Company Details
  • 11.6.2 Company Business Overview
  • 11.6.3 Novartis Pharmaceuticals Fabry Disease Therapeutic Sales, Revenue and Gross Margin (2014-2019)
  • 11.6.4 Novartis Pharmaceuticals Fabry Disease Therapeutic Products Offered
  • 11.6.5 Novartis Pharmaceuticals Recent Development
• 11.7 Pfizer
  • 11.7.1 Pfizer Company Details
  • 11.7.2 Company Business Overview
  • 11.7.3 Pfizer Fabry Disease Therapeutic Sales, Revenue and Gross Margin (2014-2019)
  • 11.7.4 Pfizer Fabry Disease Therapeutic Products Offered
  • 11.7.5 Pfizer Recent Development
• 11.8 Bristol-Myers Squibb Company
  • 11.8.1 Bristol-Myers Squibb Company Company Details
  • 11.8.2 Company Business Overview
  • 11.8.3 Bristol-Myers Squibb Company Fabry Disease Therapeutic Sales, Revenue and Gross Margin (2014-2019)
  • 11.8.4 Bristol-Myers Squibb Company Fabry Disease Therapeutic Products Offered
  • 11.8.5 Bristol-Myers Squibb Company Recent Development
• 11.9 GlaxoSmithKline plc
  • 11.9.1 GlaxoSmithKline plc Company Details
  • 11.9.2 Company Business Overview
  • 11.9.3 GlaxoSmithKline plc Fabry Disease Therapeutic Sales, Revenue and Gross Margin (2014-2019)
  • 11.9.4 GlaxoSmithKline plc Fabry Disease Therapeutic Products Offered
  • 11.9.5 GlaxoSmithKline plc Recent Development
• 11.10 Amgen Inc.
  • 11.10.1 Amgen Inc. Company Details
  • 11.10.2 Company Business Overview
  • 11.10.3 Amgen Inc. Fabry Disease Therapeutic Sales, Revenue and Gross Margin (2014-2019)
  • 11.10.4 Amgen Inc. Fabry Disease Therapeutic Products Offered
  • 11.10.5 Amgen Inc. Recent Development
• 11.11 Teva pharmaceutical Industries Ltd.
• 11.12 Merc & Co.
• 11.13 AbbVie Inc.
• 11.14 Takeda Pharmaceutical Co. Ltd.
• 11.15 Green Cross Corp.

12 Future Forecast

• 12.1 Fabry Disease Therapeutic Market Forecast by Regions
  • 12.1.1 Global Fabry Disease Therapeutic Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Fabry Disease Therapeutic Revenue Forecast by Regions 2019-2025
• 12.2 Fabry Disease Therapeutic Market Forecast by Product
  • 12.2.1 Global Fabry Disease Therapeutic Sales Forecast by Product 2019-2025
  • 12.2.2 Global Fabry Disease Therapeutic Revenue Forecast by Product 2019-2025
• 12.3 Fabry Disease Therapeutic Market Forecast by End User
• 12.4 North America Fabry Disease Therapeutic Forecast
• 12.5 Europe Fabry Disease Therapeutic Forecast
• 12.6 Asia Pacific Fabry Disease Therapeutic Forecast
• 12.7 Central & South America Fabry Disease Therapeutic Forecast
• 12.8 Middle East and Africa Fabry Disease Therapeutic Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Fabry Disease Therapeutic Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details